Zealand Pharma Enters Collaboration With D. E. Shaw Research With the Objective of Adding a New Dimension to Peptide Drug Design

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Copenhagen, 2013-06-12 14:00 CEST (GLOBE NEWSWIRE) -- - The collaboration will combine D. E. Shaw Research’s state-of-the-art computational capabilities with Zealand’s broad-based discovery and development competencies to form a potential new basis for the development of better peptide drugs.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC